Mergers and Acquisitions

Mergers and acquisitions (M&A) serve as an integral tool for BD in advancing its strategy of improving patient outcomes, reducing the cost of care, expanding access and enhancing the operations of our customers around the world. In recent years BD has completed dozens of tuck-in acquisitions including Parata Systems, Venclose, and Tepha we continue to seek out attractive opportunities which align with the strategies of BD’s businesses and regions.

BD has developed leading capabilities in transactional structuring, execution, due diligence and integration. BD's Corporate Development team partners with our businesses, functions and regions to evaluate potential opportunities. All M&A opportunities should be directed to our Corporate Development team based out of our global headquarters in Franklin Lakes, New Jersey, USA through the website submission form below.

“At BD, we employ an extremely disciplined approach to M&A through strong deal execution and integration capabilities which we have built over many years. We remain committed to our focus on expansion into high-growth adjacent markets by utilizing M&A as a tool to drive value creation and continued durable growth.”

—

Tom Polen, CEO

BD seeks inorganic opportunities that advance our long-term strategy through increasing patient access, driving better outcomes, managing system cost pressures, and improving health care safety. Directional criteria is provided below:

Differentiated technologies
Attractive underlying market growth
Global reach and application
Digital and connected devices / solutions
Medication management
Infectious disease diagnostics
Vascular access management
Surgical procedures and urological disorders
Immunology research and testing

Recent Transactions

Parata Systems

Transaction Date: July 2022

Learn more

Embecta

Transaction Date: April 2022

Learn more

Cytognos

Transaction Date: February 2022

Learn more

Venclose

Transaction Date: December 2021

Learn more

Tepha

Transaction Date: July 2021

Learn more

CubeEx

Transaction Date: November 2020

Learn more

Straub Medical

Transaction Date: June 2020

Learn more

Surgiphor

Transaction Date: May 2020

Learn more

Timeline of Disclosed Acquisitions

2022

February - Cytognos

July - Parata Systems

July - MedKeeper

2021

March - GSL Solutions
April - Velano Vascular
July - ZebraSci
July - Tepha
December - Venclose
December - Tissuemed

2020

February - NAT Diagnostics
April - Straub Medical
November - Cubex Medical
November - Surgiphor

2019

October - Adaptec
December - LifeBond

2018

June - PulsMD

July - TVA Medical

2017

April - Purewick

April - Caesarea Medical Electronics

October - FlowJo

December - C.R. Bard

2016

January - Liberator Medical

July - View'n'Vision

2015

March - CRISI Medical Systems

March - CareFusion

August - Cellular Research

November - Medicon

2014

January - Alverix

October - GenCell Biosystems

2013

March - Cato Software Solutions

July - Loma Vista Medical

October - Medafor

November - Rochester Medical

2012

February - Kiestra Lab Automation BV

August - Sirigen Group

December - Safety Syringes

Submit an acquisition opportunity

To submit an acquisition proposals on a NON-CONFIDENTIAL basis, please complete the form below. Please note, BD will be under no obligation to treat any information provided in this manner as confidential regardless of any legend or statement contained therein or set forth with respect thereto.

To submit a licensing or new product proposal: Click here